Magnetoencephalography in Children
An Observational Study on the Clinical Application of Magnetoencephalography in Children With Neurodevelopmental Disorders
1 other identifier
observational
1,500
1 country
1
Brief Summary
This study is a single-center observational clinical study, which evaluates the diagnostic value of magnetoencephalography (MEG) in the diagnosis of neurodevelopmental diseases in children, such as the localization of epileptic foci and brain functional areas, intracranial tumors, cerebrovascular diseases, autism, mental retardation, and neuropsychiatric disorders.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2024
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 25, 2024
CompletedFirst Submitted
Initial submission to the registry
October 30, 2024
CompletedFirst Posted
Study publicly available on registry
October 31, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 30, 2027
March 25, 2026
March 1, 2026
3.3 years
October 30, 2024
March 24, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Difference in magnetoencephalography (MEG) signal between children with neurodevelopmental diseases and healthy children
Acquisition of magnetoencephalography (MEG) signals based on Inclusion Criteria
3 years
Study Arms (2)
children with neurodevelopmental diseases
healthy children
Interventions
Magnetoencephalography
Eligibility Criteria
Children aged 1 month to 18 years old
You may qualify if:
- aged 1 month-18 years old (date of investigate minus date of birth)
- epilepsy
- intracranial tumors
- cerebrovascular diseases
- autism
- mental retardation
- ADHD
- tic disorder
- neuropsychiatric disorders
You may not qualify if:
- Unable to cooperate with the exam of MEG
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Children's Hospital of Fudan University
Shanghai, 201102, China
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 3 Years
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 30, 2024
First Posted
October 31, 2024
Study Start
September 25, 2024
Primary Completion (Estimated)
December 30, 2027
Study Completion (Estimated)
December 30, 2027
Last Updated
March 25, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share